Brighton Collaboration

Published this week in the ISoP Online journal, #DrugSafety: Safety and Effectiveness of COVID-19 Vaccines During Pregnancy: A Living Systematic Review and Meta-analysis: https://lnkd.in/eXcACb6g The living systematic review found a large body of evidence supporting the safety and effectiveness of COVID-19 vaccines during pregnancy. #VaccineSafety

The Companion Guide to the Brighton Collaboration Case Definition for Acute Aseptic Arthritis is now available: https://lnkd.in/eX8HQjHG Our Companion Guide includes ICD9/10-CM, MedDRA & SNOMEDCT codes, background rates, risk factors, guidance, and tools including a data abstraction & interpretation form for Acute Aseptic Arthritis. #VaccineSafety

“I want to make sure we don’t miss an opportunity to use the systems and the approach that we have to take on some of these big problems [of the future],” shared The Task Force for Global Health, Inc. President and CEO Dr. Patrick O’Carroll in a recent episode of the On Leadership with Atlanta Business Chronicle podcast, part of the WABE Studios Podcast Network. Listen to the full interview to learn more about the vision for our organization's future: https://bit.ly/4eWT6WY #40YearsofTaskForce

Exciting news! Atlanta Journal-Constitution published an extensive feature covering the genesis and history of The Task Force for Global Health, Inc., as well as success stories, our 40th anniversary, global progress on child survival, and the opening of The William H. Foege Collaboration Center at our headquarters. Read now to learn more about our work with Centers for Disease Control and Prevention, World Health Organization, UNICEF, UNDP, The World Bank, Merck, and Bill & Melinda Gates Foundation. Special thank you to Helena Oliviero for the incredible article. 🔗https://bit.ly/3XUTtes #40YearsofTaskForce

The Institute for Vaccine Safety Director, Dr. Daniel Salmon, and co-authors discuss funding for vaccine safety science in a commentary, “Establishing Ongoing Funding for Post-Authorization Vaccine Safety Science,” recently published in The New England Journal of Medicine. The United States benefits from a robust federal immunization program, which has been successful in controlling and eliminating many diseases. However, widespread vaccine hesitancy observed during the COVID-19 pandemic shows that the public is no longer satisfied with the traditional post-authorization vaccine safety goal of detecting and quantifying vaccine risks and that, when possible, the public also wants us to mitigate and prevent rare but serious adverse reactions, which no longer seem rare when vaccines are given to millions/billions of people. Read more here https://lnkd.in/gf6DUNRc or https://lnkd.in/gYTHhr2X

Recently published in The New England Journal of Medicine (NEJM Group)— "Funding Postauthorization Vaccine-Safety Science." The authors propose amending the VICP tax code in the US to link funding for #VaccineSafety monitoring with vaccine usage. Read the full article: https://lnkd.in/gf6DUNRc

#ICYMI: The Task Force for Global Health, Inc.'s CEO Dr. Patrick O’Carroll was highlighted on WSB-TV's People 2 People where he shared about The Task Force's work in his interview. Watch the first and second parts of the interview to hear about our global health impact around the world. 🌍 #40YearsofTaskForce Part 1: https://bit.ly/45PlgiF Part 2: https://bit.ly/45Rj6is

📣 🌐 Introducing International Network of Special Immunization Services - INSIS #Vaccines play a crucial role in protecting populations from infectious diseases, and ensuring their safety is of paramount importance. With the emergence of new pathogens, such as the COVID-19 virus, the need for robust safety evaluation and risk-benefit assessment of new vaccines becomes even more critical.  In response to this need, the International Network of Special Immunization Services (#INSIS) was established to advance safety evaluation and risk-benefit assessment of new vaccines for emerging pathogens through investigation of biological mechanisms underlying adverse events following immunization (AEFIs) across low-, middle-, and high-income countries. Co-led by Dr. Karina Top from University of Alberta and Dr. Robert Chen from Brighton Collaboration, INSIS brings together global experts in vaccine safety, systems biology, and genomics to characterize the clinical spectrum, risk factors, and underlying mechanisms of adverse events. ⚡ By establishing a collaborative platform, partnering with experts in low- and middle- and high-income countries, and implementing standardized approaches to AEFIs investigation, INSIS is paving the way for improved vaccine safety evaluation globally.       #INSIS employs advanced adversomics methodologies to uncover the underlying mechanisms of adverse events like myocarditis, pericarditis, and vaccine-induced thrombosis with thrombocytopenia/thrombosis with thrombocytopenia syndrome (VITT/TTS). This innovative approach integrates multi-OMICs data to define molecular pathways and predict risk, ultimately improving vaccine safety for all.    💡 By leveraging cutting-edge technologies and #global collaborations, INSIS is committed to safeguarding #publichealth and enhancing the trust in immunization programs worldwide. Link to INSIS website: https://lnkd.in/gRNzQSUa Brighton Collaboration Global Vaccine Data Network – GVDN Safety Platform for Emergency vACcines (SPEAC) University of Alberta The Task Force for Global Health, Inc. The Hospital for Sick Children Dalhousie University University of Ottawa Heart Institute McMaster University Vanderbilt University Mayo Clinic CEPI (Coalition for Epidemic Preparedness Innovations) Canadian Institutes of Health Research | Instituts de recherche en santé du Canada #VaccineSafety #GlobalHealth #COVID19 #PublicHealth #INSIS #Immunization

Brighton Collaboration Science Board member, Dr. Alejandro Cravioto, is a part of the Pan-American Advisory Group on Vaccine Safety. The Advisory Group helps national advisory groups make informed decisions about the safety of vaccines they are interested in incorporating into their immunization programs. Dr. Cravioto shares that the safety of the new #dengue vaccines has been established. “These vaccines have the potential not just to curb outbreaks, but actually to prevent cases of dengue from happening,” he says. Read the full story: https://lnkd.in/eatS-Bxs #VaccineSafety

Look forward to introducing the Brighton Collaboration case definitions and SPEAC tools to HKU colleagues. Safety Platform for Emergency vACcines (SPEAC) Brighton Collaboration